SECTION 4(A)6 OF THE SECURITIES ACT The SEC’s crowdfunding rules are found in Section 4(a)(6) of the Securities Act, known as Regulation CF. These rules have made it easier for companies to raise money from a wider range… Read More
Regulation A, also known as Regulation A+, provides investors with more investment choices and issuers with more capital raising options during their going public transactions. The rules adopting Regulation A+ are mandated by Title IV of the Jumpstart… Read More
The SEC recently granted issuers using Regulation A and Regulation Crowdfunding known as Regulation CF have been granted extensions to their SEC reporting obligations. Last month, the SEC published new temporary final rules extending the due dates for… Read More
Crowdfunding Options After Coronavirus In the past six weeks, the COVID-19 outbreak has caused quarantines and closures, and has restricted the movement of people and goods between countries and within the United States. It’s devastated certain industries and… Read More
The SEC Addresses COVID-19 Disclosure Requirements Earlier this month, the Securities and Exchange Commission (the “SEC”) addressed COVID-19 disclosure requirements in a release reminding companies subject to the SEC’s reporting requirements of their disclosure obligations regarding their… Read More
U.S. Small Business Administration Offers Funding in Response to COVID-19. The Coronavirus Preparedness and Response Supplemental Appropriations Act (the “Act”), passed with near unanimous support in both the House and Senate and was signed into law on March 6, 2020. The Act provides $20 million for the Small Business Administration (“SBA”) disaster loans program to support SBA’s administration of loans to entities financially impacted as a result of the coronavirus. Individual businesses may apply for up to $2 million of working capital loans.
The FDA recently approved an opioid-free pain-relieving cream from Honest Globe, a plant-based wellness company specializing in alternative health care. This over-the-counter topical is infused with cannabidiol (CBD) oil, an ingredient found in cannabis, originally derived from the hemp plant.
According to the company, Elixicure may be able to help those manage chronic pain without the use of narcotics.”We are ecstatic to announce that Elixicure’s Registration has been Certified by the FDA,” Elixicure’s Chief of Business Development, Yaniv Kotler said. “The FDA’s certification provides customers with an alternative to opioids for pain relief.”
This is what you need to know.
FINRA Encourages Member Firms to Provide Notice of Activities in Digital Securities Last year, FINRA took several steps to engage with its members regarding their current and planned activities relating to digital assets. These efforts included the issuance… Read More
On January 23, 2020, the Securities and Exchange Commission (SEC) issued a cease and desist order against attorney Ben Bunker (Benjamin L. Bunker). Bunker is a 42 year old lawyer based in Las Vegas, Nevada. Bunker was working… Read More
FINRA, before the New Year 2020, sanctioned five major financial firms who failing to reasonably supervise custodial accounts. These five firms were: Citigroup Global Markets Inc.; J.P. Morgan Securities LLC; LPL Financial LLC; Morgan Stanley Smith Barney LLC;… Read More